Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence Save Sight Registries Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence Read More »
Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands Save Sight Registries Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands Read More »
Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry Save Sight Registries Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry Read More »
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater Save Sight Registries Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater Read More »
Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF Save Sight Registries Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF Read More »
Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry Save Sight Registries Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry Read More »
Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia Save Sight Registries Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia Read More »
Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project Save Sight Registries Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project Read More »
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration Save Sight Registries Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration Read More »
Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration Save Sight Registries Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration Read More »
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Save Sight Registries Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration Read More »
Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study Save Sight Registries Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study Read More »
